Is your technology aligned with your organisation’s value chain?

Various new technologies are entering the pharmaceutical market and will support changes in development and manufacturing processes. Life sciences CIOs must constantly review their technology investment portfolio to anticipate future technological and regulatory changes (e.g. Live-licensing, e-CTD) and to keep the IT infrastructure aligned with the company’s value chain. Return on investment (ROI) is measured not only in monetary terms, but also in terms of the life sciences manufacturer’s ability to make informed, high-stakes technology decisions, balancing the risk of losing competitive standing with technological risks.